The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium

Por Heckl, Marlene, Schmoeckel, Elisa, Hertlein, Linda, Rottmann, Miriam, Jeschke, Udo, Mayr, Doris
Publicado no PLoS One (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †

Por Schulz, Heiko, Schmoeckel, Elisa, Kuhn, Christina, Hofmann, Simone, Mayr, Doris, Mahner, Sven, Jeschke, Udo
Publicado no Int J Mol Sci (2017)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9

Por Schulz, Heiko, Kuhn, Christina, Hofmann, Simone, Mayr, Doris, Mahner, Sven, Jeschke, Udo, Schmoeckel, Elisa
Publicado no Int J Mol Sci (2018)

Inhibition of Cdk5 induces cell death of tumor-initiating cells

Por Mandl, Melanie M, Zhang, Siwei, Ulrich, Melanie, Schmoeckel, Elisa, Mayr, Doris, Vollmar, Angelika M, Liebl, Johanna
Publicado no Br J Cancer (2017)

LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions

Por Schmoeckel, Elisa, Odai-Afotey, Ashley A., Schleiβheimer, Michael, Rottmann, Miriam, Flesken-Nikitin, Andrea, Ellenson, Lora H., Kirchner, Thomas, Mayr, Doris, Nikitin, Alexander Yu.
Publicado no Mod Pathol (2017)

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Por Semmlinger, Anna, von Schoenfeldt, Viktoria, Wolf, Verena, Meuter, Alexandra, Kolben, Theresa Maria, Kolben, Thomas, Zeder-Goess, Christine, Weis, Florian, Gallwas, Julia, Wuerstlein, Rachel, Hermelink, Kerstin, Schmoeckel, Elisa, Harbeck, Nadia, Mayr, Doris, Mahner, Sven, Jeschke, Udo, Ditsch, Nina
Publicado no BMC Cancer (2018)